HealthDot Pharma Report

Knowledge Source, Inc. in affiliation with ScribeMedia.org produces the HealthDot Pharma Report monthly. Each off-beat, but ever informative show includes discussions of hot topics in the pharmaceutical market along with occasional interviews with thought leaders in the industry.

Episode I: In Episode I of the HealthDot Pharma Report we talk business with Ogilvy Healthworld's Frank Hone, explore Genentech's Macular Degeneration conundrum with Dr. William Rich, Medical Director of Health Policy at the American Academy of Opthalmology, discuss drug re-importation and follow congressional debates surrounding biologics.

http://health.scribemedia.org/2007/03/10/pharma-report-01/

Episode II: In Episode II of the HealthDot Pharma Report we start at the intersection of Social Security, children's health, and pharmaceuticals. We brought three marketing experts together to talk about the following trends: How are pharmaceutical companies reaching consumers? How are they branding themselves? What are the opportunities? And how does advertising direct to consumers actually work? We also talked with Ed Silverman of New Jersey's Star Ledger's Pharmalot about the role of bloggers.

http://health.scribemedia.org/2007/04/16/pharma-report-02/

Episode III: In Episode III of the HealthDot Pharma Report we focus on black market medicines that lead to death, Mylan Laboratories’ acquisition of Merck’s generics unit, the (over) medication of US children and wrap it all up with a trip to Las Vegas and a conversation with Pharma Blogger John Mack.

http://health.scribemedia.org/2007/06/01/pharma-report-03/

Episode IV: We travel from the United States to Africa to Asia and back with a focus on diabetes debates (Avandia), online pharma fraud, the dangers of counterfeit malarial drugs, Nigeria’s lawsuit against Pfizer, a sensitive case of erectile malfunction and close it out with a look at Pharma Med (or combination) devices. Most importantly, Episode IV introduces Pharma Girl. A deep knowledge trove on all things pharmaceutical.

http://health.scribemedia.org/2007/06/26/pharma-report-04/

Episode V: The latest episode of the HealthDot Pharma Report investigates the weight-loss drugs and fat-reducing procedures making the news this summer. This includes GlaxoSmithKline's Alli as well as Rimonabant, a European alternative that hasn't won FDA approval due to side affects. The Pharma industry is put under the microscope in a segment called "Good Pharma / Bad Pharma." As the show host notes, "It always amazes us how an industry that does such good, that develops life saving and life changing medicines, can so often, and so clearly fall flat on its face." And finally, the effervescent Pharma Girl notes how culture appropriates Pharmaceutical motifs in a short spot on the work of bad-boy artist Damien Hirst. All this and more, in the most recent episode of the off-beat, but ever informative, HealthDot Pharma Report.

http://health.scribemedia.org/2007/09/14/pharmareport-05

Episode VI: The latest episode of the HealthDot Pharma Report takes a slightly irreverent look at bong-like delivery systems (Exubera), the tangled road of medicine and alcohol, General Therapeutics, Cell Therapeutics, Tamiflu, Trasyldol, hallucinogenic drug reactions, and the "morning after pill."

http://health.scribemedia.org/2008/02/13/pharma-report-6/

Browse Events On Demand by market segment

Also available - Company Spotlights